Cardinal Health raises FY2026 non-GAAP EPS outlook to at least $10.00, up from $9.65-$9.85

CARDINAL HEALTH INC

Raises FY2026 non-GAAP diluted EPS guidance to at least $10.00 from prior range of $9.65-$9.85.
Specialty revenues expected to exceed $50B in FY2026, a 16% CAGR over three years.
Successfully transitioned distribution agreements for all drugs affected by 2026 Medicare Drug Price Negotiation Program.
Launched ContinuCare Pathway program; Publix enrolled ~1,400 pharmacies, expanding to over 11,000 retail and grocery pharmacies.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.